Zila, Inc.
Zila is developing and commercializing oral cancer detection technology, as well as equipment used to prevent and treat periodontal disease. Its lead cancer diagnostic product is the ViziLite Plus test kit, which uses a chemiluminescent light source to detect cancerous oral lesions. Despite its FDA approval as an adjunctive diagnostic (to be used along with other methods), the ViziLite has yet to fully take off in the US. Other products include the periodontal scalers, probes, fluoride rinses, and cleaning equipment for office and home use. After experiencing financial difficulties, Zila was acquired by private drugmaker TOLMAR Holding in 2009.
Contact Details
Office Address
Zila, Inc.
16430 N. Scottsdale Rd Suite 450
Scottsdale, AZ, USA 85254
Phone: (602) 266-6700
Fax: (602) 234-2264
Executives
Executive Chairman and Interim CEO
David R. Bethune
VP Finance, Treasurer, and Principal Financial Officer
Diane E. Klein